A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
Takeda
Takeda
St. Jude Children's Research Hospital
Aga Khan University
Institute of Hematology & Blood Diseases Hospital, China
Emory University
Peking Union Medical College Hospital
University of Turin, Italy
Tianjin Medical University Cancer Institute and Hospital
Tanta University
Amgen
Peking University First Hospital
Zhejiang Cancer Hospital
The First Affiliated Hospital of Soochow University
Selcuk University